ACQUIRED PLATELET-FUNCTION DEFECTS

被引：8
作者：
BICK, RL
机构：
[1] UNIV CALIF LOS ANGELES, CTR HLTH SCI, DEPT MED, DIV HEMATOL ONCOL, LOS ANGELES, CA 90024 USA
[2] CALIF COAGULAT LABS, DALLAS, TX USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 1992年 / 6卷 / 06期
关键词：
D O I：
10.1016/S0889-8588(18)30271-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1203 / 1228
页数：26
相关论文
共 192 条
[1]  
ADAMS GA, 1982, PLASMA THER TRANSFUS, V3, P265
[2]  
ADAMS T, 1974, SCAND J HAEMATOL, V13, P215
[3]   INHIBITION OF HUMAN-PLATELET FUNCTION BY VERAPAMIL [J].
ADDONIZIO, VP ;
FISHER, CA ;
STRAUSS, JF ;
EDMUNDS, LH .
THROMBOSIS RESEARCH, 1982, 28 (04) :545-556
[4]  
Albertazzi A, 1985, Life Support Syst, V3 Suppl 1, P77
[5]   NAFCILLIN-INDUCED PLATELET DYSFUNCTION AND BLEEDING [J].
ALEXANDER, DP ;
RUSSO, ME ;
FOHRMAN, DE ;
ROTHSTEIN, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (01) :59-62
[6]   WHY SINGLE DAILY DOSE OF ASPIRIN MAY NOT PREVENT PLATELET-AGGREGATION [J].
ALTMAN, R ;
SCAZZIOTA, A ;
FUNES, JC .
THROMBOSIS RESEARCH, 1988, 51 (03) :259-266
[7]   UNSTABLE METABOLITES OF ARACHIDONIC-ACID ASPIRIN AND FORMATION OF HEMOSTATIC PLUG [J].
AMEZCUA, JL ;
PARSONS, M ;
MONCADA, S .
THROMBOSIS RESEARCH, 1978, 13 (03) :477-488
[8]  
ANDERSON ER, 1981, THROMB HAEMOSTASIS, V45, P18
[9]  
ARDLIE NG, 1967, THROMB DIATH HAEMOST, V18, P670
[10]  
ARUSIO E, 1989, REC PROG MED, V80, P18
12345678910